| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.8M | -86.6% |
| R&D Expense | $107.3M | +21.8% |
| SG&A Expense | $30.3M | +14.9% |
| Operating Income | -$134.8M | -44.3% |
| Interest Expense | $3.7M | -2.8% |
| Net Income | -$127.5M | -42.9% |
| EPS (Basic) | -$1.14 | +16.2% |
| EPS (Diluted) | -$1.14 | +16.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $178.7M | +34.0% |
| Short-term Investments | $111.4M | +89.9% |
| Current Assets | $292.7M | +50.7% |
| Total Assets | $371.1M | +36.4% |
| Current Liabilities | $36.0M | +20.6% |
| Long-term Debt | $32.1M | +6.7% |
| Total Liabilities | $130.1M | +7.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$110.8M | -80.6% |
| Capital Expenditures | $3.8M | +21.6% |
| Investing Cash Flow | -$52.6M | +13.4% |
| Financing Cash Flow | $208.8M | +54.1% |
| Free Cash Flow | -$114.6M | -77.7% |
| Stockholders' Equity |
| $241.0M |
| +59.7% |